comparemela.com
Home
Live Updates
FDA approves Takedas metastatic colorectal cancer drug : comparemela.com
FDA approves Takeda's metastatic colorectal cancer drug
A small molecule, oral targeted therapy for adults with metastatic colorectal cancer (CRC) has been approved by the US Food and Drug Administration (FDA).
Related Keywords
Macau ,
China ,
United States ,
Hong Kong ,
American ,
Cathy Eng ,
Takeda Fruzaqla ,
Weiguo Su ,
Eli Lilly ,
Teresa Bitetti ,
Journal Of The American Medical Association ,
Hutchmed China ,
Vanderbilt University Medical Center ,
Prescription Drug Users Fee Act ,
Global Oncology Business Unit ,
American Medical ,
Vanderbilt University Medical ,
Clinical Development ,
Markets Amp Regulations ,
Pis Active Pharmaceutical Ingredients ,
Regulations ,
Hutchmed ,
Colorectal Cancer ,
Research ,
Makeda ,
Clinical Trial ,
comparemela.com © 2020. All Rights Reserved.